awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39183360-1E72662C-29FB-41C7-A41B-839EA3BBB624
Q39183360-1E72662C-29FB-41C7-A41B-839EA3BBB624
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39183360-1E72662C-29FB-41C7-A41B-839EA3BBB624
Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy.
P2860
Q39183360-1E72662C-29FB-41C7-A41B-839EA3BBB624
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39183360-1E72662C-29FB-41C7-A41B-839EA3BBB624
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e88bc5e6c8d9f5fd2ef19aca9caad3aa01d2c55
P2860
Radioligand therapy with 177Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical use.